Timing is suspectIf Chambers tests are good why not release that prior to the share issue?
Reading between the lines says they aren't good, or at least not great.
Now, more than ever this relies on those results, which we don't know... And from past history we may never know, at least not directly from the company.
Clearly there are still reasons to be positive, but what is left to the imagination, left unsaid is troubling to say the least